{"id":"ragweed-pollen","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions (itching, swelling, erythema)"},{"rate":null,"effect":"Oral pruritus and throat irritation"},{"rate":null,"effect":"Systemic allergic reactions"}]},"_chembl":null,"_dailymed":{"setId":"b0a76faa-a081-4cee-ae40-e5605458bec3","title":"OUTDOOR ALLERGIES (ACONITUM NAPELLUS, ADRENALINUM, ALLIUM CEPA, RAGWEED POLLEN, ARSENICUM IODATUM, MUGWORT POLLEN, MUSTARD POLLEN, LAMBS QUARTERS POLLEN, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, PERENNIAL RYE GRASS POLLEN, ALFALFA POLLEN, TIMOTHY GRASS POLLEN, YELLOW DOCK POLLEN, SABADILLA, SILICEA, DANDELION POLLEN, RED CLOVER POLLEN, COCKLEBUR POLLEN) TABLET [NATURALCARE]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is an allergen immunotherapy product containing ragweed pollen extract that works by gradually exposing patients to increasing doses of the allergen. Over time, this exposure induces immune tolerance through shifts in T-cell responses and increased regulatory T cells, reducing IgE-mediated allergic reactions and symptoms upon natural exposure to ragweed pollen.","oneSentence":"Ragweed pollen allergen extract desensitizes the immune system to ragweed pollen through repeated controlled exposure, reducing allergic responses.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T05:25:24.035Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ragweed pollen-induced allergic rhinitis and asthma"}]},"trialDetails":[{"nctId":"NCT05346718","phase":"NA","title":"Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Fraunhofer-Institute of Toxicology and Experimental Medicine","startDate":"2022-09-01","conditions":"Allergic Rhinitis, Seasonal Allergic Rhinitis, Ragweed Allergy","enrollment":18},{"nctId":"NCT05119751","phase":"PHASE4","title":"Vestibular Versus Sublingual Route of AIT Tablets","status":"COMPLETED","sponsor":"Clinique Spécialisée en Allergies de la Capitale","startDate":"2021-10-25","conditions":"Hypersensitivity","enrollment":172},{"nctId":"NCT02676765","phase":"PHASE3","title":"Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy","status":"TERMINATED","sponsor":"Virginia Commonwealth University","startDate":"2016-06","conditions":"Immunologic Desensitization","enrollment":58},{"nctId":"NCT00109759","phase":"PHASE1","title":"Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)","status":"WITHDRAWN","sponsor":"Allergy Therapeutics","startDate":"2005-05","conditions":"Type I Hypersensitivity","enrollment":""},{"nctId":"NCT00258635","phase":"PHASE2","title":"Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test","status":"COMPLETED","sponsor":"Allergy Therapeutics","startDate":"2005-11","conditions":"Type I Hypersensitivity","enrollment":69},{"nctId":"NCT01222299","phase":"PHASE1, PHASE2","title":"Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2010-05","conditions":"Seasonal Allergic Rhinitis","enrollment":89},{"nctId":"NCT00770068","phase":"","title":"Examining the Link Between Depression and Seasonal Allergies","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2006-07-15","conditions":"Depression","enrollment":100},{"nctId":"NCT02478398","phase":"PHASE3","title":"Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1025},{"nctId":"NCT03758456","phase":"PHASE1","title":"HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human","status":"COMPLETED","sponsor":"HAL Allergy","startDate":"2018-11-21","conditions":"Rhinitis, Allergic, Rhinoconjunctivitis, Allergic","enrollment":45},{"nctId":"NCT00574210","phase":"PHASE2","title":"PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2007-10","conditions":"Seasonal Allergic Rhinitis, Hay Fever, Rhinoconjunctivitis","enrollment":502},{"nctId":"NCT00295022","phase":"PHASE4","title":"Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects","status":"COMPLETED","sponsor":"UCB S.A. - Pharma Sector","startDate":"2006-07-29","conditions":"Rhinitis, Allergic, Seasonal","enrollment":418},{"nctId":"NCT00291642","phase":"PHASE2","title":"A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-01-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":551},{"nctId":"NCT03496103","phase":"PHASE1","title":"Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2016-02-29","conditions":"Allergic Rhinitis","enrollment":29},{"nctId":"NCT02446613","phase":"PHASE2","title":"Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-06-22","conditions":"Asthma and Rhinitis","enrollment":16},{"nctId":"NCT02256553","phase":"PHASE4","title":"Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2014-10","conditions":"Rhinitis, Allergic, Seasonal","enrollment":102},{"nctId":"NCT00118729","phase":"PHASE3","title":"Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-04","conditions":"Rhinitis, Allergic, Seasonal","enrollment":380},{"nctId":"NCT01353079","phase":"PHASE3","title":"Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy","status":"COMPLETED","sponsor":"Greer Laboratories","startDate":"2011-04","conditions":"Allergy","enrollment":429},{"nctId":"NCT00599872","phase":"PHASE3","title":"Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies","status":"COMPLETED","sponsor":"Greer Laboratories","startDate":"2008-03","conditions":"Allergic Rhinitis","enrollment":430},{"nctId":"NCT00544388","phase":"PHASE3","title":"Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive Subjects","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2004-04","conditions":"Rhinitis, Allergic, Seasonal","enrollment":570},{"nctId":"NCT00315523","phase":"PHASE3","title":"Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-07","conditions":"Rhinitis, Allergic, Seasonal","enrollment":403},{"nctId":"NCT01878929","phase":"PHASE1, PHASE2","title":"The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions","status":"UNKNOWN","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2013-04","conditions":"Allergic Rhinitis, Asthma, Allergic Conjunctivitis","enrollment":245},{"nctId":"NCT00561717","phase":"PHASE4","title":"A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-10","conditions":"Seasonal Allergic Rhinitis","enrollment":70},{"nctId":"NCT01224834","phase":"PHASE1","title":"Safety and Tolerability Study of Ragweed SLIT Tablets","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2009-01","conditions":"Rhinitis, Allergic, Seasonal, Ragweed Pollen Allergy","enrollment":60},{"nctId":"NCT01033396","phase":"PHASE2","title":"The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-01","conditions":"Allergic Rhinitis","enrollment":64},{"nctId":"NCT00423787","phase":"PHASE3","title":"Efficacy and Safety/Tolerability of Ragweed MATA MPL","status":"COMPLETED","sponsor":"Allergy Therapeutics","startDate":"2007-03","conditions":"Type I Hypersensitivity","enrollment":993},{"nctId":"NCT00110786","phase":"PHASE2","title":"Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy","status":"COMPLETED","sponsor":"Allergy Therapeutics","startDate":"2005-05","conditions":"Type I Hypersensitivity","enrollment":240},{"nctId":"NCT00116285","phase":"PHASE1","title":"Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing","status":"COMPLETED","sponsor":"Allergy Therapeutics","startDate":"2005-06","conditions":"Type I Hypersensitivity","enrollment":12},{"nctId":"NCT00325338","phase":"PHASE2","title":"Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Allergy Therapeutics","startDate":"2006-05","conditions":"Type I Hypersensitivity","enrollment":100},{"nctId":"NCT00330083","phase":"PHASE1","title":"Safety of ALK Ragweed Tablet","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2006-05","conditions":"Allergy","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":806,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"ragweed pollen","genericName":"ragweed pollen","companyName":"The University of Texas Medical Branch, Galveston","companyId":"the-university-of-texas-medical-branch-galveston","modality":"Biologic","firstApprovalDate":"","aiSummary":"Ragweed pollen allergen extract desensitizes the immune system to ragweed pollen through repeated controlled exposure, reducing allergic responses. Used for Ragweed pollen-induced allergic rhinitis and asthma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}